Open AccessSUN-247 Once-Weekly Somapacitan in Childhood Growth Hormone Deficiency: Efficacy and Safety Results of a Randomized, Open-Label, Controlled Phase 2 Trial (REAL 3)
Author(s) -
Lars Sävendahl,
Michael Højby Rasmussen,
Reiko Horikawa,
Vaman Khadilkar,
Tadej Battelino,
Paul Saenger
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sun-247
Subject(s) - tolerability , medicine , growth hormone deficiency , randomized controlled trial , dosing , growth hormone , gastroenterology , endocrinology , pediatrics , adverse effect , hormone